Biodexa Pharmaceuticals Plc - BDRX
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | History | Added to | 257,472 | 159 | 0.35% | 0.62% | 1 | +66,814 | 35.04% | Q1 2026 | May 15, 2026 |
| ARMISTICE CAPITAL, LLC | History | Reduced | 97,521 | 60 | 0.0% | 0.0% | 2 | -2,479 | -2.48% | Q1 2026 | May 15, 2026 |
| GAMMA Investing LLC | History | Added to | 13,780 | 8 | 0.0% | 0.0% | 3 | +12,003 | 675.46% | Q1 2026 | Apr 06, 2026 |
| HRT FINANCIAL LP | History | Closed out | 0 | 0 | — | 0.0% | — | -10,583 | -100.0% | Q1 2026 | May 14, 2026 |
| UBS Group AG | History | Reduced | 127 | 0 | — | 0.0% | — | -1,973 | -93.95% | Q1 2026 | May 05, 2026 |
| SBI Securities Co., Ltd. | History | Added to | 151 | 0 | — | — | — | +50 | 49.5% | Q1 2026 | Apr 27, 2026 |
| RHUMBLINE ADVISERS | History | Reduced | 19 | 0 | — | — | — | -5 | -20.83% | Q1 2026 | May 12, 2026 |
| Caitong International Asset Management Co., Ltd | History | New | 1 | 0 | — | — | — | +1 | New | Q1 2026 | May 11, 2026 |
| Hilton Head Capital Partners, LLC | History | No change | 30 | 0 | — | — | — | 0 | 0.0% | Q1 2026 | Apr 20, 2026 |